English
简体中文
Total: £ 56.28
Published Date: 2025-01-21 | Pages: 91 | Tables: 93 | Medical Care
The global market for Drugs for Osteoarthritis Pain was valued at US$ 10350 million in the year 2024 and is projected to reach a revised size of US$ 15380 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.
The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.
This report aims to provide a comprehensive presentation of the global market for Drugs for Osteoarthritis Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Osteoarthritis Pain.
The Drugs for Osteoarthritis Pain market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs for Osteoarthritis Pain market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Osteoarthritis Pain companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Segment by Type
Oral
Injection
External
Segment by Application
Medical Care
Personal Care
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs for Osteoarthritis Pain company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market by Application
1.3.1 Global Drugs for Osteoarthritis Pain Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Osteoarthritis Pain Market Perspective (2020-2031)
2.2 Global Drugs for Osteoarthritis Pain Growth Trends by Region
2.2.1 Global Drugs for Osteoarthritis Pain Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drugs for Osteoarthritis Pain Historic Market Size by Region (2020-2025)
2.2.3 Drugs for Osteoarthritis Pain Forecasted Market Size by Region (2026-2031)
2.3 Drugs for Osteoarthritis Pain Market Dynamics
2.3.1 Drugs for Osteoarthritis Pain Industry Trends
2.3.2 Drugs for Osteoarthritis Pain Market Drivers
2.3.3 Drugs for Osteoarthritis Pain Market Challenges
2.3.4 Drugs for Osteoarthritis Pain Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Osteoarthritis Pain Players by Revenue
3.1.1 Global Top Drugs for Osteoarthritis Pain Players by Revenue (2020-2025)
3.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Players (2020-2025)
3.2 Global Drugs for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drugs for Osteoarthritis Pain Revenue
3.4 Global Drugs for Osteoarthritis Pain Market Concentration Ratio
3.4.1 Global Drugs for Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Osteoarthritis Pain Revenue in 2024
3.5 Global Key Players of Drugs for Osteoarthritis Pain Head office and Area Served
3.6 Global Key Players of Drugs for Osteoarthritis Pain, Product and Application
3.7 Global Key Players of Drugs for Osteoarthritis Pain, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Osteoarthritis Pain Breakdown Data by Type
4.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Type (2020-2025)
4.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2026-2031)
5 Drugs for Osteoarthritis Pain Breakdown Data by Application
5.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Application (2020-2025)
5.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drugs for Osteoarthritis Pain Market Size (2020-2031)
6.2 North America Drugs for Osteoarthritis Pain Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drugs for Osteoarthritis Pain Market Size by Country (2020-2025)
6.4 North America Drugs for Osteoarthritis Pain Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs for Osteoarthritis Pain Market Size (2020-2031)
7.2 Europe Drugs for Osteoarthritis Pain Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drugs for Osteoarthritis Pain Market Size by Country (2020-2025)
7.4 Europe Drugs for Osteoarthritis Pain Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Osteoarthritis Pain Market Size (2020-2031)
8.2 Asia-Pacific Drugs for Osteoarthritis Pain Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region (2020-2025)
8.4 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drugs for Osteoarthritis Pain Market Size (2020-2031)
9.2 Latin America Drugs for Osteoarthritis Pain Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drugs for Osteoarthritis Pain Market Size by Country (2020-2025)
9.4 Latin America Drugs for Osteoarthritis Pain Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Osteoarthritis Pain Market Size (2020-2031)
10.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2020-2025)
10.4 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Drugs for Osteoarthritis Pain Introduction
11.1.4 Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Introduction
11.2.4 Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Introduction
11.3.4 GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
11.3.5 GlaxoSmithKline Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Drugs for Osteoarthritis Pain Introduction
11.4.4 Bayer Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
11.4.5 Bayer Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Drugs for Osteoarthritis Pain Introduction
11.5.4 Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
11.5.5 Eli Lilly Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Drugs for Osteoarthritis Pain Introduction
11.6.4 Novartis Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
11.6.5 Novartis Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Drugs for Osteoarthritis Pain Introduction
11.7.4 Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
11.7.5 Sanofi Recent Development
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Details
11.8.2 Horizon Pharma Business Overview
11.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Introduction
11.8.4 Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
11.8.5 Horizon Pharma Recent Development
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Abbott Business Overview
11.9.3 Abbott Drugs for Osteoarthritis Pain Introduction
11.9.4 Abbott Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
11.9.5 Abbott Recent Development
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Drugs for Osteoarthritis Pain Introduction
11.10.4 Mylan Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
11.10.5 Mylan Recent Development
11.11 Daiichi Sankyo
11.11.1 Daiichi Sankyo Company Details
11.11.2 Daiichi Sankyo Business Overview
11.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Introduction
11.11.4 Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
11.11.5 Daiichi Sankyo Recent Development
11.12 TEVA
11.12.1 TEVA Company Details
11.12.2 TEVA Business Overview
11.12.3 TEVA Drugs for Osteoarthritis Pain Introduction
11.12.4 TEVA Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
11.12.5 TEVA Recent Development
11.13 Almatica Pharma
11.13.1 Almatica Pharma Company Details
11.13.2 Almatica Pharma Business Overview
11.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Introduction
11.13.4 Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
11.13.5 Almatica Pharma Recent Development
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Details
11.14.2 Astellas Pharma Business Overview
11.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Introduction
11.14.4 Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
11.14.5 Astellas Pharma Recent Development
11.15 Tide Pharmaceutical
11.15.1 Tide Pharmaceutical Company Details
11.15.2 Tide Pharmaceutical Business Overview
11.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Introduction
11.15.4 Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
11.15.5 Tide Pharmaceutical Recent Development
11.16 Iroko Pharmaceuticals
11.16.1 Iroko Pharmaceuticals Company Details
11.16.2 Iroko Pharmaceuticals Business Overview
11.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Introduction
11.16.4 Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
11.16.5 Iroko Pharmaceuticals Recent Development
11.17 Hengrui Pharmaceutical
11.17.1 Hengrui Pharmaceutical Company Details
11.17.2 Hengrui Pharmaceutical Business Overview
11.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Introduction
11.17.4 Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
11.17.5 Hengrui Pharmaceutical Recent Development
11.18 Abiogen Pharma
11.18.1 Abiogen Pharma Company Details
11.18.2 Abiogen Pharma Business Overview
11.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Introduction
11.18.4 Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025)
11.18.5 Abiogen Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Key Players of External
Table 5. Global Drugs for Osteoarthritis Pain Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Drugs for Osteoarthritis Pain Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Drugs for Osteoarthritis Pain Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Drugs for Osteoarthritis Pain Market Share by Region (2020-2025)
Table 9. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Drugs for Osteoarthritis Pain Market Share by Region (2026-2031)
Table 11. Drugs for Osteoarthritis Pain Market Trends
Table 12. Drugs for Osteoarthritis Pain Market Drivers
Table 13. Drugs for Osteoarthritis Pain Market Challenges
Table 14. Drugs for Osteoarthritis Pain Market Restraints
Table 15. Global Drugs for Osteoarthritis Pain Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Drugs for Osteoarthritis Pain Market Share by Players (2020-2025)
Table 17. Global Top Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2024)
Table 18. Ranking of Global Top Drugs for Osteoarthritis Pain Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Drugs for Osteoarthritis Pain Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Drugs for Osteoarthritis Pain, Headquarters and Area Served
Table 21. Global Key Players of Drugs for Osteoarthritis Pain, Product and Application
Table 22. Global Key Players of Drugs for Osteoarthritis Pain, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2020-2025)
Table 26. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2026-2031)
Table 28. Global Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2020-2025)
Table 30. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2026-2031)
Table 32. North America Drugs for Osteoarthritis Pain Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Drugs for Osteoarthritis Pain Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Drugs for Osteoarthritis Pain Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Drugs for Osteoarthritis Pain Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Drugs for Osteoarthritis Pain Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Drugs for Osteoarthritis Pain Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Drugs for Osteoarthritis Pain Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Drugs for Osteoarthritis Pain Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Drugs for Osteoarthritis Pain Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Drugs for Osteoarthritis Pain Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2026-2031) & (US$ Million)
Table 47. Pfizer Company Details
Table 48. Pfizer Business Overview
Table 49. Pfizer Drugs for Osteoarthritis Pain Product
Table 50. Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Johnson & Johnson Company Details
Table 53. Johnson & Johnson Business Overview
Table 54. Johnson & Johnson Drugs for Osteoarthritis Pain Product
Table 55. Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 56. Johnson & Johnson Recent Development
Table 57. GlaxoSmithKline Company Details
Table 58. GlaxoSmithKline Business Overview
Table 59. GlaxoSmithKline Drugs for Osteoarthritis Pain Product
Table 60. GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 61. GlaxoSmithKline Recent Development
Table 62. Bayer Company Details
Table 63. Bayer Business Overview
Table 64. Bayer Drugs for Osteoarthritis Pain Product
Table 65. Bayer Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 66. Bayer Recent Development
Table 67. Eli Lilly Company Details
Table 68. Eli Lilly Business Overview
Table 69. Eli Lilly Drugs for Osteoarthritis Pain Product
Table 70. Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 71. Eli Lilly Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Drugs for Osteoarthritis Pain Product
Table 75. Novartis Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Sanofi Company Details
Table 78. Sanofi Business Overview
Table 79. Sanofi Drugs for Osteoarthritis Pain Product
Table 80. Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 81. Sanofi Recent Development
Table 82. Horizon Pharma Company Details
Table 83. Horizon Pharma Business Overview
Table 84. Horizon Pharma Drugs for Osteoarthritis Pain Product
Table 85. Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 86. Horizon Pharma Recent Development
Table 87. Abbott Company Details
Table 88. Abbott Business Overview
Table 89. Abbott Drugs for Osteoarthritis Pain Product
Table 90. Abbott Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 91. Abbott Recent Development
Table 92. Mylan Company Details
Table 93. Mylan Business Overview
Table 94. Mylan Drugs for Osteoarthritis Pain Product
Table 95. Mylan Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 96. Mylan Recent Development
Table 97. Daiichi Sankyo Company Details
Table 98. Daiichi Sankyo Business Overview
Table 99. Daiichi Sankyo Drugs for Osteoarthritis Pain Product
Table 100. Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 101. Daiichi Sankyo Recent Development
Table 102. TEVA Company Details
Table 103. TEVA Business Overview
Table 104. TEVA Drugs for Osteoarthritis Pain Product
Table 105. TEVA Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 106. TEVA Recent Development
Table 107. Almatica Pharma Company Details
Table 108. Almatica Pharma Business Overview
Table 109. Almatica Pharma Drugs for Osteoarthritis Pain Product
Table 110. Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 111. Almatica Pharma Recent Development
Table 112. Astellas Pharma Company Details
Table 113. Astellas Pharma Business Overview
Table 114. Astellas Pharma Drugs for Osteoarthritis Pain Product
Table 115. Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 116. Astellas Pharma Recent Development
Table 117. Tide Pharmaceutical Company Details
Table 118. Tide Pharmaceutical Business Overview
Table 119. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 120. Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 121. Tide Pharmaceutical Recent Development
Table 122. Iroko Pharmaceuticals Company Details
Table 123. Iroko Pharmaceuticals Business Overview
Table 124. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product
Table 125. Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 126. Iroko Pharmaceuticals Recent Development
Table 127. Hengrui Pharmaceutical Company Details
Table 128. Hengrui Pharmaceutical Business Overview
Table 129. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 130. Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 131. Hengrui Pharmaceutical Recent Development
Table 132. Abiogen Pharma Company Details
Table 133. Abiogen Pharma Business Overview
Table 134. Abiogen Pharma Drugs for Osteoarthritis Pain Product
Table 135. Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2020-2025) & (US$ Million)
Table 136. Abiogen Pharma Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
Table 140. Authors List of This Report
List of Figures
Figure 1. Drugs for Osteoarthritis Pain Picture
Figure 2. Global Drugs for Osteoarthritis Pain Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drugs for Osteoarthritis Pain Market Share by Type: 2024 VS 2031
Figure 4. Oral Features
Figure 5. Injection Features
Figure 6. External Features
Figure 7. Global Drugs for Osteoarthritis Pain Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Drugs for Osteoarthritis Pain Market Share by Application: 2024 VS 2031
Figure 9. Medical Care Case Studies
Figure 10. Personal Care Case Studies
Figure 11. Drugs for Osteoarthritis Pain Report Years Considered
Figure 12. Global Drugs for Osteoarthritis Pain Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Drugs for Osteoarthritis Pain Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Drugs for Osteoarthritis Pain Market Share by Region: 2024 VS 2031
Figure 15. Global Drugs for Osteoarthritis Pain Market Share by Players in 2024
Figure 16. Global Top Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Drugs for Osteoarthritis Pain Revenue in 2024
Figure 18. North America Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Drugs for Osteoarthritis Pain Market Share by Country (2020-2031)
Figure 20. United States Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Drugs for Osteoarthritis Pain Market Share by Country (2020-2031)
Figure 24. Germany Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Drugs for Osteoarthritis Pain Market Share by Region (2020-2031)
Figure 32. China Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Drugs for Osteoarthritis Pain Market Share by Country (2020-2031)
Figure 40. Mexico Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Drugs for Osteoarthritis Pain Market Share by Country (2020-2031)
Figure 44. Turkey Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Drugs for Osteoarthritis Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 48. Johnson & Johnson Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 50. Bayer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 51. Eli Lilly Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 52. Novartis Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 53. Sanofi Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 54. Horizon Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 55. Abbott Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 56. Mylan Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 57. Daiichi Sankyo Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 58. TEVA Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 59. Almatica Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 60. Astellas Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 61. Tide Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 62. Iroko Pharmaceuticals Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 63. Hengrui Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 64. Abiogen Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
